1. Home
  2. EHTH vs ELOX Comparison

EHTH vs ELOX Comparison

Compare EHTH & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EHTH

eHealth Inc.

HOLD

Current Price

$1.47

Market Cap

52.4M

Sector

Finance

ML Signal

HOLD

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$12.36

Market Cap

43.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
EHTH
ELOX
Founded
1997
N/A
Country
United States
United States
Employees
N/A
7
Industry
Specialty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
52.4M
43.8M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
EHTH
ELOX
Price
$1.47
$12.36
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$3.33
N/A
AVG Volume (30 Days)
491.6K
22.6K
Earning Date
05-06-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
71.43
N/A
EPS
N/A
N/A
Revenue
$251,395,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
45.86
N/A
52 Week Low
$1.20
$10.00
52 Week High
$5.89
$14.28

Technical Indicators

Market Signals
Indicator
EHTH
ELOX
Relative Strength Index (RSI) 40.02 32.17
Support Level $1.43 N/A
Resistance Level $1.58 N/A
Average True Range (ATR) 0.14 2.09
MACD -0.02 -0.18
Stochastic Oscillator 9.20 64.60

Price Performance

Historical Comparison
EHTH
ELOX

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is derived from the United States. It also has a presence in China.

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Share on Social Networks: